Neoplasms Metastasis Withdrawn Phase 2 Trials for Everolimus (DB01590)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01178151Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers SyndromeTreatment